FDA’s Role in Access to Reproductive Health Care
Recent abortion pill litigation underscores the significance of calls to make birth control pills available over the counter.
The Supreme Court and the Future of the Internet
Upcoming Supreme Court decisions may reshape the legal risks facing tech companies.
School Transportation and Educational Equity
School transportation resources must increase to achieve mobility justice.
Sustainable Transportation for Rural Communities
Regulators must redress transportation inequities in rural and disadvantaged communities.
Opening the Skies to Passengers Who Use Wheelchairs
Airline transportation needs to address accessibility issues for passengers with disabilities.
Mobility Justice
Experts discuss how regulators can make transportation systems more accessible and just.
Disability and the Right to Move in the World
Current regulations limit accessibility of air travel to people with disabilities.
Merger Law Is Dante’s Inferno Revisited
The shift by agencies away from the current guidelines on mergers and acquisitions has left firms in limbo.
Jimmy Carter, The Great Deregulator
By pushing for deregulation and adopting other reforms, President Carter left an enduring legacy on the U.S. regulatory system.
FDA Advances Program for Real-World Evidence
FDA’s approach to evidence-based decision-making may not be addressed to the right people.
Virginia Charts a Path Forward on Regulatory Modernization
New agency sets example for state and federal agencies to follow in analyzing regulatory costs and benefits.
Net-Zero Emission Pledges May Not Lead to Full Decarbonization
Examining countries’ net-zero pledges reveals variations and loopholes that will allow for slippage in climate progress.